to 31 January 2019 announced 21 March 2019
Sigma Healthcare Limited
Full Year Results
Important Notice
The material provided is a presentation of general information about Sigma's activities current at the date of the presentation. It is information given in summary form and does not purport to be complete. No representation or warranty is made as to its completeness, accuracy or reliability. Any forward looking information in this presentation has been prepared on the basis of a number of assumptions which may prove to be incorrect.
Known and unknown risks, uncertainties and other factors, many of which are beyond Sigma's control, may cause actual results to differ materially. Nothing in this presentation should be construed as a recommendation or forecast by Sigma or an offer to sell or a solicitation to buy or sell shares.
This presentation also contains certain non-IFRS measures that Sigma believe are relevant and appropriate for the understanding of the financial results.
Overview
Mark Hooper, CEO and Managing Director
1. Key Highlights
2. Financial Performance
3. Business Transformation
4. Outlook
Key Highlights - building a better future
Results are ahead of current guidance
High Dividend Payout Ratio maintained
Our strategy and future direction is clear
$100+ million efficiency gains identified to be delivered over 18-24 months
Roadmap for FY23 EBITDA to be around the same level as FY19
Investment cycle well advanced
Balance Sheet will be strong with debt reduced to circa $100m by end of FY20 which provides capacity for significant growth
Against this backdrop, the API Merger Proposal was not in the best interests of shareholders
API Merger Proposal - background
Proposal received from API - 0.31 API share plus $0.23 cash for every Sigma share.
API announced in December 2018 they had acquired 12.96% of Sigma shares
Reciprocal high level due diligence completed - validated the $60 million of potential synergy benefits
Having now completed our detailed assessment, Sigma rejected the offer as it is not in the best interests of shareholders
Sigma is confident it has a strong future independent of this proposal
Attachments
- Original document
- Permalink
Disclaimer
Sigma Healthcare Limited published this content on 21 March 2019 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 20 March 2019 22:39:05 UTC